Recent Finacing
Recent Raise
Biohaven is a New Haven–based biopharmaceutical company focused on late‑stage clinical development of neurologic drug assets, licensing academic IP and advancing Phase 2/3 trials in orphan indications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Biohaven Pharmaceutical.
